Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCOC antisense RNA 1 (SCOC-AS1)
- Target
- SCOC-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
SCOC antisense RNA 1 (SCOC-AS1) is an antisense long non-coding RNA transcribed from a locus opposite the SCOC gene. Antisense lncRNAs are a class of non-protein-coding transcripts longer than 200 nucleotides that play diverse roles in gene regulation at multiple levels, including transcription, RNA processing, and translation through mechanisms such as mRNA stabilization, interference, or chromatin remodeling[1][2][3]. While SCOC-AS1 itself is not documented as a therapeutic target, nor have its functions been characterized in detail, its classification as an antisense lncRNA suggests potential involvement in fine-tuning gene expression of nearby coding loci, as reported for other antisense lncRNAs[1][2][5]. No current evidence suggests that SCOC-AS1 is associated with specific drugs, disease biomarkers, or safety concerns.
- Other names
- LOC124900785SCOC-AS1
02
Mechanism of action
Not applicable; no drugs nor targeted therapeutic mechanisms documented
03
Biological functions
Regulation of gene expressionPossible modulation of neighboring gene function (based on known activities of antisense lncRNAs)
04
Disease associations
Potential roles in cancer and other diseases (inferred from broader antisense lncRNA literature, direct association with specific diseases for SCOC-AS1 not documented)
Beyond the preview
Go deeper on SCOC antisense RNA 1 (SCOC-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCOC antisense RNA 1 (SCOC-AS1).